zPREDICTA Company
zPREDICTA’s bio-simulation technology combines biology with automation and computation to automate drug development. zPREDICTA's bio-simulation platform enables pharma to rapidly identify drug candidates that will be effective in patients.
r-Organ is a set of next generation 3D culture models that provide 1-to-1 reconstruction of human tissue microenvironment in an organ- and disease-specific manner allowing accurate prediction of drug response. Utilizing r-Organ technology, zPREDICTA is mapping cellular behavior in response to anticancer drugs.
Total Funding:
100000
Founded Date:
2014-01-01
Industry:
Quantum Biology
Last Funding Date:
2016-06-01
Funding Status:
private
Headquarters:
San Jose,California,United States,North America
Super Industry:
Quantum Science Applications
Funding Stage:
M&A
Funding Total Value:
100000
Last Funding Total Usd:
100000
Last Funding Total Currency:
USD
Last Funding Total Value:
100000
Founders:
Julia Kirshner,Mukti Parikh